Skip to main content

IVISbrite LNCaP Red F-luc Bioluminescent Tumor Cell line (Bioware Brite)

The IVISbrite LNCaP Red F-luc tumor cell line (Bioware® Brite LNCaP-Red-FLuc) is a light-producing cell line derived from LNCaP human prostate carcinoma. The cells have been stably transduced with the red-shifted firefly luciferase gene from Luciola Italica (Red F-luc), for a brighter, red-shifted signal.

For research use only. Not for use in diagnostic procedures.


IVISbrite LNCaP Red F-luc Bioluminescent Tumor Cell line

  • Organism: Human
  • Tissue: Prostate; supraclavicular lymph node
  • Disease: Carcinoma
  • Optical Reporter: Red F-luc

By emitting intensified, longer wavelength light that is significantly brighter than other firefly luciferases, our bioluminescent oncology cell lines allow you to visualize and monitor the growth of deep tissue tumors in vivo.

After the cells are injected into an appropriate mouse model, the optimized Red F-luc luciferase enables more sensitive in vivo optical detection with less tissue attenuation so you can detect tumor development earlier, and monitor tumor growth and metastases in both subcutaneous and orthotopic models.


Cancer Model
Imaging Modality
Luciferase Classification
Quantity in a Package Amount
2.0 Vials
Shipping Conditions
Shipped in Dry Ice
Unit Size
2 vials each containing 1 million cells


1-1 of 1 Resources
In vivo imaging solutions

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...

SDS, COAs, Manuals and more Illuminator

SDS, COAs, Manuals and more

Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.

Scroll Icon